British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 - PubMed (original) (raw)
Practice Guideline
. 2017 Sep;177(3):628-636.
doi: 10.1111/bjd.15665.
Z K Jabbar-Lopez 1, Z Z Yiu 2, T Bale 3, A D Burden 4, L C Coates 5 6, M Cruickshank 7, T Hadoke 8, E MacMahon 9, R Murphy 10, C Nelson-Piercy 11, C M Owen 12, R Parslew 13, E Peleva 1, E Pottinger 7, E J Samarasekera 7, J Stoddart 14, C Strudwicke 8, V A Venning 15, R B Warren 2, L S Exton 16, M F Mohd Mustapa 16
Affiliations
- PMID: 28513835
- DOI: 10.1111/bjd.15665
Practice Guideline
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
C H Smith et al. Br J Dermatol. 2017 Sep.
No abstract available
Similar articles
- British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; (Chair of Guideline Group). Smith CH, et al. Br J Dermatol. 2009 Nov;161(5):987-1019. doi: 10.1111/j.1365-2133.2009.09505.x. Br J Dermatol. 2009. PMID: 19857207 No abstract available. - A review of neurologic complications of biologic therapy in plaque psoriasis.
Lin EJ, Reddy S, Shah VV, Wu JJ. Lin EJ, et al. Cutis. 2018 Jan;101(1):57-60. Cutis. 2018. PMID: 29529105 Review. - Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Iskandar IYK, Ashcroft DM, Warren RB, Evans I, McElhone K, Owen CM, Burden AD, Smith CH, Reynolds NJ, Griffiths CEM. Iskandar IYK, et al. Br J Dermatol. 2017 May;176(5):1297-1307. doi: 10.1111/bjd.15027. Epub 2017 Mar 20. Br J Dermatol. 2017. PMID: 27589476 - Adverse reactions of biological therapy for psoriasis.
Brănişteanu DE, Voicu CM, Creţu A, Dimitriu A, Luca MC, Sălăvăstru CM. Brănişteanu DE, et al. Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):38-44. Rev Med Chir Soc Med Nat Iasi. 2015. PMID: 25970940 - Tuberculosis in the age of biologic therapy.
Hernandez C, Cetner AS, Jordan JE, Puangsuvan SN, Robinson JK. Hernandez C, et al. J Am Acad Dermatol. 2008 Sep;59(3):363-80; quiz 382-4. doi: 10.1016/j.jaad.2008.05.033. J Am Acad Dermatol. 2008. PMID: 18694676 Review.
Cited by
- Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry.
Gulliver WP, See K, Zhu B, Konicek BW, Harrison RW, McLean RR, Kerti SJ, Burge RT, Leonardi CL. Gulliver WP, et al. J Psoriasis Psoriatic Arthritis. 2023 Apr;8(2):74-82. doi: 10.1177/24755303231155118. Epub 2023 Mar 21. J Psoriasis Psoriatic Arthritis. 2023. PMID: 39296674 Free PMC article. - Cost-effectiveness analysis of biologic sequential treatments for moderate-to-severe psoriasis: A Malaysian healthcare system perspective.
Azizam NA, Hussain M, Nauenberg E, Ang WC, Azzeri A, Smith J. Azizam NA, et al. PLoS One. 2024 Sep 6;19(9):e0307234. doi: 10.1371/journal.pone.0307234. eCollection 2024. PLoS One. 2024. PMID: 39240834 Free PMC article. - Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries.
Raam L, Hartmane I, Valiukevičienė S, Karamova AE, Telegdy E, Botev I, Marina D, Rubant S, Albuquerque T, Constantin MM. Raam L, et al. Front Immunol. 2024 May 23;15:1410540. doi: 10.3389/fimmu.2024.1410540. eCollection 2024. Front Immunol. 2024. PMID: 38846952 Free PMC article. - Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain.
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Cebolla-Verdugo M, Prados-Carmona A, Hernández-Montoya C, Armario-Hita JC, Galán-Gutiérrez M. Ruiz-Villaverde R, et al. Life (Basel). 2024 Feb 20;14(3):281. doi: 10.3390/life14030281. Life (Basel). 2024. PMID: 38541607 Free PMC article. - The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
Al-Homood IA, Al Ghanim N, Fatani MIA, Hussein AH, Alolaiwi AM, Abualiat A, Alqurtas E, Alomari BAA, Khardaly AM, Alenzi KAO, Albarakati RG, Almudaiheem HY, Al-Jedai A, Eshmawi MTY. Al-Homood IA, et al. Clin Rheumatol. 2024 Mar;43(3):879-894. doi: 10.1007/s10067-024-06867-x. Epub 2024 Jan 13. Clin Rheumatol. 2024. PMID: 38217738 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical